معرفی
Aloke Dutta, Ph.D., is a Professor in the Department of Pharmaceutical Sciences at the Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University. With over two decades of experience at Wayne State, Dr. Dutta has established himself as a leading researcher in central nervous system drug discovery, with particular focus on neurodegenerative diseases, depression, and drug addiction.
Dr. Dutta received his Master of Science degree in Chemistry from Calcutta University, India, before earning his doctorate in Organic Chemistry from Ohio University in 1987. Following a postdoctoral fellowship at the University of Minnesota, he worked at Organix, Inc. before joining Wayne State University as an Associate Professor in 1998, where he was promoted to Full Professor in 2005.
Dr. Dutta's research program integrates medicinal chemistry, neuropharmacology, computational chemistry, and molecular biology to develop novel central nervous system drugs. His laboratory focuses on creating multifunctional molecules that target monoamine transporters and receptor systems to treat Parkinson's disease, depression, and drug addiction. For Parkinson's disease, his team designs compounds that not only provide symptomatic relief but also offer neuroprotective effects to slow or halt disease progression. In depression research, they've developed novel triple reuptake inhibitors to address anhedonia in major depressive disorder. This innovative approach to CNS drug discovery has resulted in numerous patents and promising lead compounds currently under preclinical development.
Analysis of Dr. Dutta's publication record shows a clear progression toward increasingly sophisticated multifunctional compounds that address multiple pathological mechanisms in neurological disorders. His recent work demonstrates particular expertise in designing molecules that simultaneously target dopamine receptors, modulate protein aggregation, and provide neuroprotective benefits through metal chelation and antioxidant properties.
- Outstanding Research Achievement Award from the Eugene Applebaum College of Pharmacy and Health Sciences (2011)
Dr. Dutta has successfully secured over $10 million in NIH research funding throughout his career, with current support from NIDA, NINDS, and NIMH. His laboratory has trained numerous graduate students and postdoctoral fellows who have gone on to successful careers in academia and the pharmaceutical industry. Dr. Dutta serves on multiple NIH study sections and has been a reviewer for numerous prestigious journals in the field.
The Dutta Lab maintains strong interdisciplinary collaborations across the biomedical field and continues to push the boundaries of CNS drug discovery, with several compounds in advanced preclinical development for Parkinson's disease, depression, and PTSD. Current research focuses on translating promising lead compounds into viable therapeutic candidates with disease-modifying potential.
